logo
Epstein case fallout reaches fevered pitch with reports FBI's Dan Bongino could resign

Epstein case fallout reaches fevered pitch with reports FBI's Dan Bongino could resign

Yahoo20 hours ago
The fallout from a Justice Department memo that appeared to close the Jeffrey Epstein case reached a fevered pitch this week amid reports that a top FBI official may resign.
FBI Deputy Director Dan Bongino, the second-highest official at the bureau, didn't come into work on July 11, various news outlets reported. What's more, the former Secret Service agent and Fox News show host is weighing leaving the bureau altogether, less than four months after joining it, according to CNN and Semafor, which each cited sources familiar with the situation.
The FBI didn't immediately respond to USA TODAY's request for comment.
The developments come after the Justice Department and FBI released a memo July 7 stating that a "systematic review" of evidence failed to reveal any incriminating client list associated with Jeffrey Epstein, a disgraced financier and convicted sex offender who died in his jail cell in 2019 as he awaited trial on sex-trafficking charges.
"Perpetuating unfounded theories about Epstein serves neither" to combat child exploitation nor bring justice to victims, the memo said. "No further disclosure would be appropriate or warranted."
Many loyalists of President Donald Trump have been incensed by the memo, which followed years of suggestions by Trump associates that the government was hiding a list of Epstein clients who may have been involved in sex trafficking and that Epstein may have been murdered to prevent those names from becoming public.
New York's chief medical examiner ruled in 2019 that Epstein died by suicide, and the Justice Department's memo backs up that finding.
More: Trump's team promised transparency on Epstein. Here's what they delivered.
The memo threw a range of conservative commentators into an uproar.
"I'm going to go throw up, actually," right-wing radio show host Alex Jones said in a July 7 video post on X, as his eyes teared up. "I just really need the Trump administration to succeed ... and then for them to do something like this – tears my guts out."
Bongino himself sounded alarm bells well before he took on a top role in Trump's FBI.
"There are a lot of people who are knee-deep in the Washington swamp who are not telling you the truth about serious allegations out there that Epstein may have had video and audio of people out there doing things they shouldn't have been doing," Bongino said on his "The Dan Bongino Show" on May 1, 2023.
"Jeffrey Epstein isn't with us anymore, and nobody seems to want to talk about it outside of a few entrepreneurial media outlets saying, 'Hey, this is a big deal,'" Bongino added.
Attorney General Pam Bondi recently fanned the flames of those espousing a government cover-up about the Epstein evidence. Bondi characterized the Biden administration's effort on the case as lackluster, telling Fox News host Sean Hannity on March 3 that she had instructed the FBI to review a "truckload" of Epstein files that were delivered as a result of an order she issued in February.
"It's infuriating that these people (the Biden administration) thought that they could sit on this information, but they can't. It's a new day, and we believe in transparency, and it's going to come out," Bondi said.
However, Bondi largely seemed to close the door on future revelations at a July 8 cabinet meeting following the memo's release. She said various videos within the review turned out to be child sexual abuse materials, but said her department was looking for some further videos it hoped to release in connection with Epstein's jail facility.
"And that's it on Epstein," Bondi said.
Deputy Attorney General Todd Blanche, the second-highest official at the Justice Department after Bondi, said in a July 11 post on X that he'd worked closely with Bongino and FBI Director Kash Patel on the polarizing memo and they'd mutually signed off on its contents and conclusions.
"The suggestion by anyone that there was any daylight between the FBI and DOJ leadership on this memo's composition and release is patently false," Blanche said.
This article originally appeared on USA TODAY: Epstein fallout looms large amid reports top FBI official may resign
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's
DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's

Associated Press

time28 minutes ago

  • Associated Press

DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's

While busting cartels, DEA continues war on science and suffering patients. Duane Boise, CEO of MMJ International Holdings, expressed frustration over the contrasting approaches of federal agencies, stating, 'While the FDA is facilitating medical innovation, the DEA's hindrance not only blocks scientific progress but also contradicts directives aimed at revitalizing domestic manufacturing.' This situation starkly contrasts with the 'Buy American' initiative endorsed by President Trump, which was intended to strengthen U.S. drug production capabilities and reduce dependence on foreign manufacturers. WASHINGTON, DC / ACCESS Newswire / July 13, 2025 / In a historic move, the Drug Enforcement Administration (DEA), alongside California officials, seized over $123 million in illegal cannabis in California's Central Valley. Touted as the largest cannabis eradication operation in state history, this multi-agency sweep destroyed 105,700 illegal plants and over 22,000 pounds of processed product-dealing a powerful blow to criminal diversion networks. But while the DEA proudly parades its enforcement success, it continues to obstruct a very different kind of cannabis operation-one backed by the FDA, supported by Congress, and desperately needed by patients. Why is the DEA targeting drug cartels, while simultaneously blocking science and medical progress? The DEA Operation: A Win Against Illicit Growers During the week of May 5, a coordinated task force involving the DEA, California National Guard, state and local law enforcement, and the Department of Fish and Wildlife executed dozens of warrants across Kern, Tulare, and Kings counties. Nine firearms were seized and multiple individuals arrested. 'This operation demonstrates the power of collaboration to dismantle criminal enterprises,' said California officials. But one form of cannabis remains untouched: federally compliant, FDA authorized medical cannabis research. DEA's Double Standard: Criminal Cartels Get Raided-Pharmaceutical Innovation Gets Sabotaged Despite this public victory, the DEA's track record tells a darker story: It targets illegal grows tainted with pesticides and mold But blocks companies like MMJ BioPharma Cultivation, which holds: Yet the agency continues to deny MMJ a bulk manufacturing license after nearly seven years of delay-citing retroactive 'Catch-22" policies and hiding behind a broken administrative law system. Obstructing Science While Crime Thrives While criminal operations flood state-legal markets with contaminated cannabis, the DEA has stood by, doing little to protect public health-until now. But even this long-overdue enforcement does not excuse the agency's refusal to act on federally authorized medical research. 'This isn't just negligence-it's sabotage,' said Duane Boise, CEO of MMJ BioPharma. 'We followed every federal rule, obtained FDA approvals, and proved our security protocols. The DEA's refusal to grant a license has delayed critical treatment for patients suffering from Huntington's Disease and Multiple Sclerosis.' A National Embarrassment MMJ BioPharma's situation has become a symbol of DEA dysfunction: Meanwhile, illicit grows flourish-and so does patient suffering. The Path Forward: Reform, Not Excuses With President Trump threatening 200% tariffs to bring pharmaceutical manufacturing back to U.S. soil, the DEA's outdated war on cannabis could derail America's pharmaceutical future before it starts. MMJ BioPharma calls for the following immediate actions: Remove DEA roadblocks to FDA-approved medical cannabis research Transfer cannabis pharmaceutical oversight to the FDA or NIH Investigate the DEA Diversion Control Division for systemic obstruction A Final Word: 'The DEA cannot be allowed to fight cartels with one hand and choke science with the other,' said Boise. 'Lives are on the line. We need enforcement-but we also need research progress.' MMJ is represented by attorney Megan Sheehan. CONTACT: Madison Hisey [email protected] 203-231-85832 SOURCE: MMJ International Holdings press release

Trump attends soccer final in leadup to hosting World Cup
Trump attends soccer final in leadup to hosting World Cup

Washington Post

time32 minutes ago

  • Washington Post

Trump attends soccer final in leadup to hosting World Cup

EAST RUTHERFORD, N.J. — President Donald Trump stood and saluted from a suite at midfield Sunday, briefly the center of attention amid the final match of a global competition that has been a precursor for a much bigger event next year. Sunday's FIFA Club World Cup Final at MetLife Stadium pitted Chelsea FC against Paris Saint-Germain, culminating weeks of competition in U.S. stadiums. It was something of a test run for the World Cup, which will feature the same top names in the sport playing on behalf of their national teams.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store